CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,045 enrolled
Drug / intervention
Pantoprazoledrug
Likely dose
Pantoprazole 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00830115
NCT00830115N/ACompleted
CompareCT.gov

Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders

Nycomed·observational·Posted Jan 27, 2009·Updated May 8, 2012

In Brief

An observational study evaluating Pantoprazole for Sleep Disorders and 2 related conditions. Completed, enrolled 1,045 participants across 201 sites.

Detailed Summary

The aim of the study was to evaluate the effect of pantoprazole on sleep disorders in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease). The prevalence and intensity of the sleep disorders were evaluated by a standardized questionnaire. The study was expected to provide further data on safety and tolerability of pantoprazole.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Disorders, Non-Erosive Reflux Disease, Gastroesophageal Reflux Disease
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 27, 2009
Enrollment StartJan 1, 2009
Primary CompletionMay 1, 2009
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.4 years ago

Interventions

Pantoprazoledrug

Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).